Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Dear

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Archives of Toxicology|January 19, 2025
BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicityPatricia Marañón, Stephania C Isaza, Esther Rey, et al.
Ebiomedicine|July 18, 2019
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)Emma E Morrison, Katherine Oatey, Bernadette Gallagher, et al.
Journal of Translational Medicine|January 7, 2012
Identification and proteomic profiling of exosomes in human cerebrospinal fluidJonathan M Street, Perdita E Barran, C Logan Mackay, et al.
Hepatology (Baltimore, Md.)|April 21, 2015
Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver InjuryDaniel J Antoine, Venkata S Sabbisetti, Ben Francis, et al.
British Journal of Clinical Pharmacology|January 12, 2021
MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infectionSarah A E Rupprechter, Derek J Sloan, Wilna Oosthuyzen, et al.
BMC Medical Genomics|April 8, 2020
Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdoseDanny Laurent, Fiona Semple, Philip J Starkey Lewis, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 10, 2012
'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoningDouglas B Murray, Stephen Potts, Carole Haxton, et al.
BMC Pharmacology & Toxicology|April 6, 2013
Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP)H K Ruben Thanacoody, Alasdair Gray, James W Dear, et al.
BMJ Open|December 16, 2021
Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platformErin Gaughan, Tom Quinn, Annya Bruce, et al.
British Journal of Clinical Pharmacology|August 11, 2025
Adverse drug reactions, particularly liver disorders, drive interruptions in anti-tuberculosis treatment: A retrospective cohort studyEleanor G Dixon, Evita Biraua, Edvards Brencsēns, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Archives of Toxicology|January 19, 2025
BMP6 participates in the molecular mechanisms involved in APAP hepatotoxicityPatricia Marañón, Stephania C Isaza, Esther Rey, et al.
Ebiomedicine|July 18, 2019
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)Emma E Morrison, Katherine Oatey, Bernadette Gallagher, et al.
Journal of Translational Medicine|January 7, 2012
Identification and proteomic profiling of exosomes in human cerebrospinal fluidJonathan M Street, Perdita E Barran, C Logan Mackay, et al.
Hepatology (Baltimore, Md.)|April 21, 2015
Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver InjuryDaniel J Antoine, Venkata S Sabbisetti, Ben Francis, et al.
British Journal of Clinical Pharmacology|January 12, 2021
MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infectionSarah A E Rupprechter, Derek J Sloan, Wilna Oosthuyzen, et al.
BMC Medical Genomics|April 8, 2020
Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdoseDanny Laurent, Fiona Semple, Philip J Starkey Lewis, et al.
Clinical Toxicology (Philadelphia, Pa.)|January 10, 2012
'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoningDouglas B Murray, Stephen Potts, Carole Haxton, et al.
BMC Pharmacology & Toxicology|April 6, 2013
Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP)H K Ruben Thanacoody, Alasdair Gray, James W Dear, et al.
BMJ Open|December 16, 2021
Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platformErin Gaughan, Tom Quinn, Annya Bruce, et al.
British Journal of Clinical Pharmacology|August 11, 2025
Adverse drug reactions, particularly liver disorders, drive interruptions in anti-tuberculosis treatment: A retrospective cohort studyEleanor G Dixon, Evita Biraua, Edvards Brencsēns, et al.
Pageof 14